In summary, we have identified PSMD2 as an oncogenic protein in ESCC and demonstrated their effects on autophagy inhibition via activating the ASS1-mTOR pathway, which significantly promotes ESCC cell proliferation in vitro and ESCC growth in vivo. This evidence concerns the gene MTOR and esophageal squamous cell carcinoma.